Locally advanced breast carcinoma treated with neoadjuvant chemotherapy: are the changes in serum levels of YKL-40, MMP-2 and MMP-9 correlated with tumor response?

Coskun, U; Yamac, D; Gulbahar, O; Sancak, B; Karaman, N; Ozkan, S

Coskun, U; Yamac, D; Gulbahar, O; Sancak, B; Karaman, N; Ozkan, S.

Affiliation

Coskun U; Gazi University Medical School, Department of Medical Oncology, Ankara, Turkey. ugurcos@hotmail.com

Neoplasma ; 54(4): 348-52, 2007.

Article in En | MEDLINE | ID: mdl-17845129

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Breast Neoplasms/drug therapy; Glycoproteins/blood; Matrix Metalloproteinase 2/blood; Matrix Metalloproteinase 9/blood; Neoadjuvant Therapy; Adipokines; Adult; Aged; Biomarkers, Tumor/blood; Breast Neoplasms/blood; Chemotherapy, Adjuvant; Chitinase-3-Like Protein 1; Cyclophosphamide/therapeutic use; Doxorubicin/therapeutic use; Female; Fluorouracil/therapeutic use; Humans; Lectins; Middle Aged; Neoplasm Staging; Prognosis; Survival Rate; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Glycoproteins / Antineoplastic Combined Chemotherapy Protocols / Neoadjuvant Therapy / Matrix Metalloproteinase 2 / Matrix Metalloproteinase 9 Type of study: Guideline / Prognostic_studies Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: Neoplasma Year: 2007 Document type: Article Affiliation country: Turkey

Search on Google

Add to My VHL

XML

PubMed Links